Reduction of ischemic events in Improved Reduction of Outcomes: Vytorin Efficacy International Trial: Intensive cholesterol lowering or ezetimibe antithrombotic effects?
Publication
, Journal Article
Pesaro, AEP; Granger, CB; Lopes, RD
Published in: Am Heart J
February 2016
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Am Heart J
DOI
EISSN
1097-6744
Publication Date
February 2016
Volume
172
Start / End Page
42 / 44
Location
United States
Related Subject Headings
- Treatment Outcome
- Randomized Controlled Trials as Topic
- Incidence
- Humans
- Ezetimibe, Simvastatin Drug Combination
- Ezetimibe
- Dose-Response Relationship, Drug
- Cholesterol
- Cardiovascular System & Hematology
- Brazil
Citation
APA
Chicago
ICMJE
MLA
NLM
Pesaro, A. E. P., Granger, C. B., & Lopes, R. D. (2016). Reduction of ischemic events in Improved Reduction of Outcomes: Vytorin Efficacy International Trial: Intensive cholesterol lowering or ezetimibe antithrombotic effects? Am Heart J, 172, 42–44. https://doi.org/10.1016/j.ahj.2015.11.001
Pesaro, Antonio Eduardo P., Christopher B. Granger, and Renato D. Lopes. “Reduction of ischemic events in Improved Reduction of Outcomes: Vytorin Efficacy International Trial: Intensive cholesterol lowering or ezetimibe antithrombotic effects?” Am Heart J 172 (February 2016): 42–44. https://doi.org/10.1016/j.ahj.2015.11.001.
Pesaro AEP, Granger CB, Lopes RD. Reduction of ischemic events in Improved Reduction of Outcomes: Vytorin Efficacy International Trial: Intensive cholesterol lowering or ezetimibe antithrombotic effects? Am Heart J. 2016 Feb;172:42–4.
Pesaro, Antonio Eduardo P., et al. “Reduction of ischemic events in Improved Reduction of Outcomes: Vytorin Efficacy International Trial: Intensive cholesterol lowering or ezetimibe antithrombotic effects?” Am Heart J, vol. 172, Feb. 2016, pp. 42–44. Pubmed, doi:10.1016/j.ahj.2015.11.001.
Pesaro AEP, Granger CB, Lopes RD. Reduction of ischemic events in Improved Reduction of Outcomes: Vytorin Efficacy International Trial: Intensive cholesterol lowering or ezetimibe antithrombotic effects? Am Heart J. 2016 Feb;172:42–44.
Published In
Am Heart J
DOI
EISSN
1097-6744
Publication Date
February 2016
Volume
172
Start / End Page
42 / 44
Location
United States
Related Subject Headings
- Treatment Outcome
- Randomized Controlled Trials as Topic
- Incidence
- Humans
- Ezetimibe, Simvastatin Drug Combination
- Ezetimibe
- Dose-Response Relationship, Drug
- Cholesterol
- Cardiovascular System & Hematology
- Brazil